%20(1).png){kind=small}
.png){kind=small}
%20(1).png){kind=small}
%20(1)%20(1).png)
The Endocannabinoid System in Animals: An Educational Guide
- Romas Marcin
- May 21
- 8 min read
Quick takeaway: The endocannabinoid system (ECS) is a biological network found in all mammals — dogs, cats, horses, humans, and others. It's made up of two primary receptor types (CB1 and CB2), the endocannabinoids the body produces naturally, and the enzymes that synthesize and break down these compounds. Research on the ECS is still relatively new — it was first identified in the 1990s — and our understanding continues to evolve. This guide is educational science, not veterinary advice. Always consult your veterinarian before introducing CBD or any supplement to your pet's routine.
If you've been researching CBD for pets, you've likely come across mentions of the "endocannabinoid system" or "ECS." Understanding what this system is — and isn't — helps put cannabinoid research into context for any pet owner.
This guide covers what the ECS is, how it was discovered, where it's found in animal biology, the difference between endocannabinoids and plant cannabinoids, and what's still being researched. It's educational science content — we're not making claims about what CBD does for any specific animal or condition.
What the Endocannabinoid System Is
The endocannabinoid system is a biological signaling network that exists in all mammals. It's made up of three main components:
Endocannabinoids — compounds the body produces naturally that act as signaling molecules. The two most studied endocannabinoids are anandamide (AEA) and 2-arachidonoylglycerol (2-AG).
Cannabinoid receptors — proteins on cell surfaces that endocannabinoids bind to. The two primary receptor types are CB1 and CB2.
Enzymes — proteins that synthesize endocannabinoids when needed and break them down when their work is done.
These three components work together to maintain various physiological processes throughout the body. The ECS is one of many biological signaling systems mammals have evolved.
How the Endocannabinoid System Was Discovered
The endocannabinoid system is a relatively recent scientific discovery — its components were first identified in the early 1990s:
1988: Researchers discovered cannabinoid receptors in animal brain tissue, leading to the identification of CB1
1990: The CB1 receptor was successfully cloned
1992: Anandamide (the first known endocannabinoid) was identified by Dr. Raphael Mechoulam and colleagues
1993: The CB2 receptor was identified
1995: 2-AG was identified as the second major endocannabinoid
The system was named after the Cannabis sativa plant because the discovery of plant cannabinoids (like THC and CBD) predated the discovery of the endogenous (internally produced) cannabinoid system. Researchers found the receptors that THC interacted with first, then worked backward to discover the body's own cannabinoid-like molecules.
Why this history matters: the ECS is a relatively young area of biological research. Many questions about how it functions, particularly in specific animals and specific situations, remain active areas of study. Anyone who claims definitive answers about exactly how the ECS responds to specific compounds is likely overstating what's currently established.
The Two Primary Cannabinoid Receptors
The ECS has two main receptor types, found in different locations throughout the body:
CB1 Receptors
Primary location: Central nervous system — concentrated in the brain and along the spinal cord
Also found in: Some peripheral organs and tissues
Associated with: Various neurological processes that researchers are still mapping
CB2 Receptors
Primary location: Peripheral nervous system, immune system tissues, and various organs
Also found in: Throughout the body in lower concentrations
Associated with: Various peripheral biological processes still being studied
This distribution pattern is found across mammalian species — dogs, cats, horses, and humans all have similar CB1 and CB2 receptor distributions, though the exact density and locations can vary by species.
Endocannabinoids vs. Plant Cannabinoids
Two categories of compounds interact with the ECS:
Endocannabinoids (Produced by the Body)
Anandamide (AEA) — sometimes called the "bliss molecule" because its name comes from the Sanskrit word for bliss
2-Arachidonoylglycerol (2-AG) — the most abundant endocannabinoid in the body
Both are produced as needed and broken down by specific enzymes after their work is done
Phytocannabinoids (Plant-Derived)
CBD (cannabidiol) — non-intoxicating compound from hemp
THC (delta-9 tetrahydrocannabinol) — the intoxicating compound in marijuana
CBG, CBN, CBC and dozens of others — additional cannabinoids found in cannabis plants
The cannabis plant produces phytocannabinoids that happen to interact with the same receptor systems that the body's own endocannabinoids use. This is why plant cannabinoids are biologically relevant in mammals — they're interacting with an existing biological system, not creating a new one.
How CBD Interacts With the ECS
Without making any claims about effects or benefits, here's what's understood about how CBD interacts with the endocannabinoid system:
CBD doesn't bind directly to CB1 or CB2 receptors the way THC does. Instead, CBD interacts with these receptors indirectly and with various other receptor systems.
CBD may affect how endocannabinoids are broken down by influencing certain enzymes — specifically by potentially affecting how anandamide is degraded.
CBD interacts with multiple receptor systems beyond just CB1 and CB2 — including serotonin receptors, TRP channels, and others. Researchers continue to study these interactions.
The specific outcomes of these interactions in any given animal or situation are still being studied. Research is ongoing in both animal and human contexts.
This is the honest scientific picture: CBD interacts with the ECS in measurable ways, but the specifics of what that means biologically for any given animal in any given context is research in progress.
The Endocannabinoid System Across Different Animals
Mammals across species have the endocannabinoid system. Some specifics:
Dogs
Dogs have a well-developed endocannabinoid system with CB1 and CB2 receptors distributed throughout their bodies. Important note about dogs specifically: dogs are particularly sensitive to THC compared to humans (and other mammals). This is why broad-spectrum or isolate CBD products (with non-detectable THC) are typically the appropriate choice for canine use rather than full-spectrum products. For more on CBD considerations specifically for dogs, see our CBD for Dogs guide.
Cats
Cats also have an endocannabinoid system. Their CB receptor distribution is similar to other mammals, but cats have some unique metabolic differences from dogs that affect how they process various compounds. Cat-specific cannabinoid research is less developed than canine research. Always consult an experienced veterinarian for any cat-specific questions.
Horses
Horses have the ECS like all mammals, with CB1 and CB2 receptors distributed throughout their bodies. Equine cannabinoid research has grown alongside the growing equine wellness market. For practical considerations for horse owners, see our CBD for Horses guide.
Other Animals
The ECS is found across mammals broadly. Some non-mammal species (fish, certain reptiles, etc.) also have cannabinoid-like signaling systems, though they differ from the mammalian ECS in various ways. Most cannabinoid research in animals focuses on mammals — particularly rodents in laboratory research, and dogs and horses in companion animal research.
What Research Is Still Working On
Honest framing requires acknowledging what's not yet settled:
Specific effects of cannabinoids in specific animals and conditions — most cannabinoid research is still in early stages
Optimal dosing for animals — established veterinary dosing guidelines for CBD are still being developed
Drug interactions — understanding of how CBD interacts with various pet medications continues to evolve
Long-term use studies — particularly in companion animals, long-term studies are limited
Species-specific differences — how the ECS varies between species in functionally meaningful ways
Anyone presenting cannabinoid effects in animals as settled science is overstating what's currently established. The honest answer is: there's enough research to make ECS biology a legitimate topic, but not enough to make definitive claims about specific outcomes.
What This Means for Pet Owners
The practical implication of this educational background:
CBD interacts with the same biological system in your pet that it does in you. This is why pet owners often consider CBD as part of their pets' wellness routines.
Research is still developing. Be skeptical of any product or article making definitive claims about what CBD does for animals. The honest position is "we're learning."
Your veterinarian is the best decision partner. Especially if your pet is on other medications, has specific health considerations, or is older. CBD is not a substitute for veterinary care.
Choose products designed for animal use. Broad-spectrum or isolate products (non-detectable THC) are typically the safer choice for pets — particularly dogs, who are more THC-sensitive than humans.
Quality matters. Look for third-party lab tested products with batch-specific Certificates of Analysis from reputable brands.
GoGreen Hemp's Approach to Pet Products
For pet-focused CBD considerations, we offer:
CBD for Dogs — pet-formulated products designed for canine use
Unflavored CBD Tinctures — work for various animal uses, including equine
All products are:
Broad-spectrum with non-detectable THC verified per batch
Third-party lab tested with public Certificates of Analysis
U.S.-grown hemp, CO2 extracted
Manufactured in a facility that follows GMP (Good Manufacturing Practices) protocols
Frequently Asked Questions
What is the endocannabinoid system?
The endocannabinoid system (ECS) is a biological signaling network found in all mammals. It's made up of endocannabinoids (compounds the body produces), cannabinoid receptors (CB1 and CB2), and the enzymes that synthesize and break down these compounds. It was first identified in the 1990s and remains an active area of research.
Do animals have an endocannabinoid system?
Yes. All mammals — dogs, cats, horses, humans, and others — have the endocannabinoid system. The receptor distribution and biology are broadly similar across mammalian species, though specifics can vary between species.
Which animals have an endocannabinoid system?
The ECS is found across mammals. Some non-mammal species have cannabinoid-like signaling systems, but the mammalian ECS is what most pet-related cannabinoid research focuses on.
What are CB1 and CB2 receptors?
CB1 and CB2 are the two primary cannabinoid receptors in the endocannabinoid system. CB1 receptors are concentrated in the central nervous system (brain and spinal cord). CB2 receptors are concentrated in the peripheral nervous system, immune system tissues, and various organs. Both receptor types are found across mammalian species.
What does the endocannabinoid system do?
The ECS is involved in various biological signaling processes in mammals. Research continues to map exactly which processes the ECS affects and how. Honest framing acknowledges that while the ECS is real and important, the specifics of what it does in any given situation are still being studied.
How does CBD interact with the endocannabinoid system?
CBD interacts with the ECS in multiple ways. Unlike THC, CBD doesn't bind directly to CB1 or CB2 receptors. Instead, it influences these receptors indirectly and interacts with several other receptor systems including serotonin receptors and TRP channels. The specific outcomes of these interactions remain an active area of research.
When was the endocannabinoid system discovered?
The ECS was first identified in the early 1990s. CB1 receptors were discovered in 1988, anandamide (the first known endocannabinoid) was identified in 1992, and CB2 receptors were identified in 1993. The system is named after the cannabis plant because plant cannabinoids were known and studied before the body's own cannabinoid system was identified.
Is research on the animal ECS settled or ongoing?
Ongoing. The ECS itself is a well-established biological system, but research on how cannabinoids affect specific outcomes in specific animals continues to develop. Be skeptical of any source making definitive claims about specific effects.
What's the difference between endocannabinoids and phytocannabinoids?
Endocannabinoids are produced by the body (animals and humans both produce them). The two main ones are anandamide and 2-AG. Phytocannabinoids are produced by the cannabis plant — CBD, THC, CBG, CBN, and dozens of others. Both interact with the same receptor systems.
Should I talk to my vet about CBD for my pet?
Yes. Your veterinarian is the authoritative source for decisions about your specific pet's health and supplements. This is especially important if your pet is on any medications, has specific health considerations, or is older. CBD is not a substitute for veterinary care.
Final Thoughts
The endocannabinoid system is a real, biologically significant signaling network found in all mammals. Understanding it provides useful context for thinking about cannabinoids in animal biology.
What the ECS isn't is a magic system that explains exactly what CBD does for any specific pet in any specific situation. Research is still developing, and honest discussion of cannabinoids in animals requires acknowledging that uncertainty.
For pet owners considering CBD, the practical advice remains: talk to your veterinarian, choose quality lab-tested products, start cautiously, and observe over time.
About the Author
Romas Marcin — Founder, GoGreen Hemp
Romas founded GoGreen Hemp in 2016 and has spent nearly a decade studying cannabinoids, the endocannabinoid system, and the hemp industry. He leads product development and quality standards across all GoGreen Hemp products — including pet-focused formulations designed with the same lab-testing transparency as the human product line.
These statements have not been evaluated by the Food and Drug Administration. Hemp-derived products are not intended to diagnose, treat, cure, or prevent any disease or condition. This article provides general educational information and is not veterinary advice. Always consult your veterinarian before adding CBD or any new supplement to your pet's routine.
Comments